Textile electrodes for medtech applications

The founders of Nahtlos AG José Näf and Michel Schmid with the textile-based electrodes for long-term ECGs in their laboratory in St. Gallen.
Credit: Marlies Thurnheer / Empa

Nahtlos, an Empa spin-off, has received 1 million Swiss francs in a first round of financing from a network of business angels from Switzerland and Liechtenstein and from the Startfeld Foundation. With this funding, Nahtlos aims to drive the market entry of its newly developed textile-based electrode for medical applications.

Over the past two years, Nahtlos, an Empa spin-off, has developed novel textile-based electrodes for recording heart activity (electrocardiogram, ECG) – for example, to detect atrial fibrillation – and for electrostimulation therapies, for example, to preserve the muscle mass in paralyzed patients. Textile-based electrodes enable gentle and skin-friendly application, even if the electrodes have to be worn for several days or even weeks. The textile electrode is thus the first alternative to the gel electrode, which was developed 60 years ago and is still considered the standard for medical applications today.

Nahtlos founder and former Empa researcher Michel Schmid and co-founder and business economist José Näf have further developed the textile-based technology, which was developed and patented at Empa in various projects funded by Innosuisse, among others. The goal was to produce a product for long-term medical applications that reliably records ECG signals for up to several weeks, achieves a high level of patient acceptance and is cost-effective for the healthcare provider. Today, the patent for textile-based elecrtrode technology is owned by Nahtlos after reaching a milestone.

Financing by business angels and Startfeld Foundation

Schmid and Näf were looking for investors to certify their product, set up production and develop the market – and recently found what they were looking for: In a seed financing round, the two young entrepreneurs were able to acquire 1 million Swiss francs from business angels from Switzerland and Liechtenstein as well as from the Startfeld Foundation. Nahtlos was supported in setting up its company by Startfeld, the start-up promotion arm of Switzerland Innovation Park Ost (SIP Ost), in the form of coaching, consulting and early-stage financing. Nahtlos is also based in the Innovation Park Ost, where innovations are initiated and accelerated through collaboration between start-ups, companies, universities and research institutions.

Together with Empa and Nahtlos, SIP Ost will also be present at OLMA this year. At booth 45 in hall 3.1, visitors can learn live and on the spot about Empa’s research activities in the field of Digital Health as well as about the Nahtlos technology and its textile electrodes for health monitoring.

Wissenschaftliche Ansprechpartner:

Prof. Dr. René Rossi
Empa, Biomimetic Membranes and Textiles
Phone +41 58 765 77 65
rene.rossi@empa.ch

José Näf
Nahtlos AG
Phone +41 79 504 23 19
jose.naef@nahtlos.com

Weitere Informationen:

https://www.empa.ch/web/s604/spin-off-nahtlos Empa media release

Media Contact

Rainer Klose Kommunikation
Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All latest news from the category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to home

Comments (0)

Write a comment

Newest articles

Milestone 10-GeV experiment shines light on laser-plasma interactions

With dual lasers and an advanced gas injector system, researchers at the Berkeley Lab Laser Accelerator Center accelerated a high-quality beam of electrons to 10 billion electronvolts in just 30…

Universal barcodes unlock fast-paced small molecule synthesis

The development of molecules to study and treat disease is becoming increasingly burdened by the time and specificity required to analyze the vast amounts of data generated by synthesizing large…

Minuscule robots for targeted drug delivery

In the future, delivering therapeutic drugs exactly where they are needed within the body could be the task of miniature robots. Not little metal humanoid or even bio-mimicking robots; think…